Related Experiment Videos
Oncogene products as therapeutic targets for cancer
1Department of Cancer Research, Merck Research Laboratories, West Point, PA 19486, USA.
Abstract:
Enormous progress has been made in the last several years in delineating signal transduction pathways associated with cell proliferation and apoptosis. The components of these pathways, which include both oncogenes and tumor suppressors, may provide viable targets for therapeutic intervention for the treatment of cancer and other diseases. This review highlights some of these recent biologic and pharmacologic advances, focusing on the ras pathway and on p53-dependent apoptosis.
Insights
Recent advances in understanding cell signaling pathways, including the ras pathway and p53-dependent apoptosis, offer promising therapeutic targets for cancer treatment.
Area of Science:
- Molecular Biology
- Cancer Research
- Pharmacology
Background:
- Signal transduction pathways regulate fundamental cellular processes like proliferation and apoptosis.
- Dysregulation of these pathways is implicated in cancer development and progression.
- Oncogenes and tumor suppressors within these pathways represent key therapeutic targets.
Purpose of the Study:
- To review recent biologic and pharmacologic advances in signal transduction.
- To highlight progress in understanding the ras pathway and p53-dependent apoptosis.
- To identify potential therapeutic strategies for cancer and other diseases.
Main Methods:
- Literature review of recent scientific publications.
- Focus on studies detailing the ras signaling pathway.
- Analysis of research on p53-mediated apoptosis.
Main Results:
- Significant progress has been made in delineating key signal transduction pathways.
- Components like oncogenes and tumor suppressors are identified as viable therapeutic targets.
- Specific focus on the ras pathway and p53-dependent apoptosis reveals therapeutic potential.
Conclusions:
- Understanding signal transduction pathways is crucial for cancer therapy.
- The ras pathway and p53-dependent apoptosis are critical areas for therapeutic intervention.
- Recent advances provide a foundation for developing novel anti-cancer treatments.